Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06388629

Epicardial Access Study With Rook

Led by Circa Scientific, Inc. · Updated on 2024-08-21

40

Participants Needed

1

Research Sites

43 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to test how how effective the Circa Scientific Rook® Epicardial Access Kit is at gaining guidewire access to the outside surface of the heart (epicardium). In addition the safety of the device will be compared to the available data for alternative methods of epicardial access. Participants will receive treatment with the subject device during the course of a typical epicardial electrophysiology procedure.

CONDITIONS

Official Title

Epicardial Access Study With Rook

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient is clinically indicated to undergo a procedure that requires percutaneous access to the normal, non-distended, pericardial space.
  • Patient is willing and able to provide written informed consent.
Not Eligible

You will not qualify if you...

  • Subject is younger than 18 years of age
  • Previous cardiac surgery
  • Myocardial infarction within 4 weeks prior to procedure
  • Class IV NYHA (New York Heart Association) heart failure symptoms
  • Subject with an active systemic infection
  • Known carotid artery stenosis greater than 80%
  • Presence of thrombus in the left atrium
  • Congenital absence of a pericardium
  • Coagulopathy
  • Hemodynamic Instability
  • Acute conditions (i.e. electrolyte abnormality, acute ischemia, drug toxicity)
  • Severe hepatic dysfunction or enlargement
  • Subject has Body Mass Index > 40
  • Life expectancy less than 6 months
  • Subject is pregnant
  • Subject is currently participating in another investigational drug or device study that clinically interferes with the endpoints of this study
  • Subject has known or suspected allergy to contrast media
  • Subject is known to have pericardial fibrosis, pericardial adhesions, or prior failed epicardial access

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Na Homolce Hospital

Prague, Czechia, 15030

Actively Recruiting

Loading map...

Research Team

D

David Director of Product Development

CONTACT

A

Alice Regulatory Affairs Manager, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here